Minerva Neurosciences | NERV - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Adma Biologics USD 136.02M 2.13M 2026-06
ALKERMES USD 511.53M 159.98M 2026-06
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
AstraZeneca USD 4.89B 2.67B 2026-06
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Cipla INR 10.18B 2.22B 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
CSL USD 2.16B 633M 2025-06
Eli Lilly USD 8.95B 3.67B 2026-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
J&J USD 20.42B 1.27B 2026-06
Merck USD 6.85B 1.52B 2026-06
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 7.62B 739M 2026-06
Novavax USD 191.46M 36.9M 2026-06
Pfizer USD 976M 727M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06
Takeda JPY 460.98B 134.07B 2026-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12